Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
15
Genomic Health, Inc. announced results from a study demonstrating the critical role of manual microdissection to remove all biopsy cavities from breast cancer specimens. Genomic Health's Oncotype DX is the only commercially available breast cancer test that employs manual microdissection following review by a board certified surgical pathologist with breast expertise to predict a patient's benefit from chemotherapy and risk of disease recurrence.
14
In honor of National Breast Cancer Awareness Month, a group of women known as the BRAC (Be Ready Against Cancer) Pack has stepped up its efforts to encourage genetic testing for breast and ovarian cancer. The women are advocates for BRACAnalysis, a lab test that looks for mutations on the BRCA1 and BRCA2 genes, which are associated with an increased risk of breast and ovarian cancer.
The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Guidelines for Cervical Cancer Screening to provide further recommendations for a subset of women with conflicting results on cervical cytology/Pap tests and Human papillomavirus (HPV) High Risk DNA tests.
13
Over the last several years, unprecedented numbers of men have elected to undergo robotically assisted surgery for prostate cancer in the belief that the less invasive approach would give them a better chance of maintaining normal sexual function and avoiding incontinence.
CeloNova BioSciences, Inc. has received approval from its European regulatory body, the British Standards Institution, to expand the list of medical indications for which Embozene(TM) Microspheres may be used and to add a tenth size of the product.
We were ready to start a family when a mammogram revealed an abnormal mass in my left breast, said Staci Sansolo, 34, of New Jersey. A biopsy revealed the mass was not cancer, but a second- round test found another area of concern.
Can your breath help diagnose breast cancer? Researchers from the Georgia Tech Research Institute and Emory Winship Cancer Institute think it might. They are adapting a process typically used in Europe to test for occupational exposure to contaminants and using it to detect the presence of breast cancer.
12
Although breast cancer remains one of the most- often diagnosed cancers in women each year, methods to improve the detection and elimination of cancerous cells are being discovered, developed and tested each day around the world with plans to deliver them to tomorrow's markets, say researchers at the Purdue Research Park of West Lafayette .
When a mammogram detected a lump in Barbara Laufer's breast, the fear was paralyzing. You think you're going to die, says Laufer, 40, of Burbank, Calif. Laufer was diagnosed with a perplexing condition called ductal carcinoma in situ, or DCIS, a growth of malignant cells inside the milk ducts of the breast. Though some doctors describe the condition to patients as a very early breast cancer, others compare it to a precancer.
Clinical experience with the FDA cleared Axxent (R) Electronic Brachytherapy, eBx(TM), System from Xoft shows promise for the multi- disciplinary use of the isotope-free cancer treatment platform to deliver intraoperative radiation therapy (IORT). Xoft will showcase a variety of investigational IORT oncology applications at the American College of Surgeons 95th Annual Clinical Congress here in Chicago, October 11-15, 2009.
We care about your feedback. Let us know how we can improve your CancerCompass experience.